Your SlideShare is downloading. ×
Metastatic cancer – pipeline review, h2 2012
Metastatic cancer – pipeline review, h2 2012
Metastatic cancer – pipeline review, h2 2012
Metastatic cancer – pipeline review, h2 2012
Metastatic cancer – pipeline review, h2 2012
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Metastatic cancer – pipeline review, h2 2012

60

Published on

2012 | Aarkstore.com || Metastatic cancer – pipeline review, h2 2012

2012 | Aarkstore.com || Metastatic cancer – pipeline review, h2 2012

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
60
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Metastatic Cancer – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Metastatic Cancer - Pipeline Review, H2 2012, provides anoverview of the indication’s therapeutic pipeline. This report provides informationon the therapeutic development for Metastatic Cancer, complete with latest updates,and special features on late-stage and discontinued projects. It also reviews keyplayers involved in the therapeutic development for Metastatic Cancer. MetastaticCancer - Pipeline Review, Half Year is built using data and information sourced fromGlobal Markets Direct’s proprietary databases, Company/University websites, SECfilings, investor presentations and featured press releases from company/universitysites and industry-specific third party sources, put together by Global MarketsDirect’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Metastatic Cancer.- A review of the Metastatic Cancer products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.
  2. - Coverage of products based on various stages of development ranging fromdiscovery till registration stages.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Metastatic Cancer.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.Table of contents:List of Tables 20List of Figures 24Introduction 25Global Markets Direct Report Coverage 25Metastatic Cancer Overview 26Therapeutics Development 27An Overview of Pipeline Products for Metastatic Cancer 27Metastatic Cancer Therapeutics under Development by Companies 29Metastatic Cancer Therapeutics under Investigation by Universities/Institutes 43Metastatic Cancer Therapeutics – Products under Development by Companies 67Metastatic Cancer Therapeutics – Products under Investigation byUniversities/Institutes 97Companies Involved in Metastatic Cancer Therapeutics Development 150Bristol-Myers Squibb Company 150Johnson & Johnson 151Boehringer Ingelheim GmbH 152F. Hoffmann-La Roche Ltd. 153Kyowa Hakko Kirin Co., Ltd. 154Celsion Corporation 155Abbott Laboratories 156Vical Incorporated 157Amgen Inc. 158Sanofi-Aventis 159
  3. Adherex Technologies Inc. 160AstraZeneca PLC 161Eli Lilly and Company 162Viralytics Ltd. 163GlaxoSmithKline plc 164Tekmira Pharmaceuticals Corp. 165Bionovo, Inc. 223Cytokinetics, Inc 224Telik, Inc. 225List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012Respiratory Depression – Pipeline Review, H2 2012Metastatic Cancer – Pipeline Review, H2 2012Viral Infections – Pipeline Review, H2 2012Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
  4. Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×